The effect of Cardiac rehabilitation educational program on risk factors and functional capacity of patients with coronary artery disease

The effect of Cardiac rehabilitation educational program on risk factors and functional capacity of patients with coronary artery disease in Ali ibn abitaleb hospital, Zahedan, 1397

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180110038298N2

Enrollment

Registered

2018-08-01

Start date

2018-08-03

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease. Atherosclerotic heart disease of native coronary artery

Interventions

Intervention 1: Intervention group: Includes 35 patients undergoing a cardiac rehabilitation program within twelve weeks. The program consists of four lecture sessions and a questionnaire that focuse

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Diagnosis of coronary artery disease is done by a specialist, confirming the results of diagnostic tests The first hospital admission is due to coronary artery disease Ejection fraction is between 25 to 40% The hemodynamic status at the start of the rehabilitation program is stable Age between 25 and 65 years old Ability to walk without help Reside in Zahedan City

Exclusion criteria

Exclusion criteria: There is no serious arrhythmia when the rehab program starts Have not COPD, pulmonary artery pressure and right heart problems Lack of history of heart surgery and not being a candidate for CABG

Design outcomes

Primary

Measure	Time frame
Cardiac Rehabilitation educational Program. Timepoint: Before discharge and then the end of the study in the twelfth week. Method of measurement: blood sample, 6 minute walk test.	—

Secondary

Measure	Time frame
Blood glucose. Timepoint: Before discharge and then the end of the study in the twelfth week. Method of measurement: blood sample.;Blood lipid profile. Timepoint: Before discharge and then the end of the study in the twelfth week. Method of measurement: blood sample.;Waist Circumference. Timepoint: Before discharge and then the end of the study in the twelfth week. Method of measurement: Measuring with meter.;Waist–hip ratio. Timepoint: Before discharge and then the end of the study in the twelfth week. Method of measurement: The number obtained by dividing the waist circumference of the hip circumference.;6 minute walk test. Timepoint: Before discharge and then the end of the study in the twelfth week. Method of measurement: The distance traveled in a six minute walk test per meter.	—

Measure

Time frame

Blood glucose. Timepoint: Before discharge and then the end of the study in the twelfth week. Method of measurement: blood sample.;Blood lipid profile. Timepoint: Before discharge and then the end of the study in the twelfth week. Method of measurement: blood sample.;Waist Circumference. Timepoint: Before discharge and then the end of the study in the twelfth week. Method of measurement: Measuring with meter.;Waist–hip ratio. Timepoint: Before discharge and then the end of the study in the twelfth week. Method of measurement: The number obtained by dividing the waist circumference of the hip circumference.;6 minute walk test. Timepoint: Before discharge and then the end of the study in the twelfth week. Method of measurement: The distance traveled in a six minute walk test per meter.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAzam Shabazi Dehsookhte

Zahedan University of Medical Sciences

shahbazi.azam92@gmail.com+98 54 3344 2482

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026